- ( ). 2 2 * Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209 2 :. 2 72 : 8. Stratified. 500 HbAC 2. : HbAC 2... 0. HbAC :. 2 : - -2 - - -5 : emrc@tums.ac.ir : 02 88220052 : 02 8822007 : 88//28: 88/0/26 : 88/8/20 :
... : 70 Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209 [ ]... [6 7 ] [5]. [8] [9] [20 2] [22]..[2].[2] mrna.[25].. 2 72 ).(87 86.[] 2 [2] [] 2....[]. [5] [6 7] [8]..[9]..[0 ]. [ 2].[2].[2] 2. - C-terminal cross-linked telopeptide of type I collagen
7 ( ). Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209 75 2 20 250. ( ) GOD/PAP HPLC (HbAC) (High Pressure Liquid Chromatography) DS5 Ingland. Bioscience (Nortic Bioscience Diagnostic A/S (CV),Denmark) 2.. % /7 %2/6 Bioscience (Nortic Bioscience Diagnostic A/S,Denmark) % 5/. % 6/6 ELISA 0pg/ml % 7/5 % / 5 Human visfatin ELISA kit,adipogen ).(Pharmaceuticals, Belmont, Seoul Korea ELISA 00pg/ml %/82 %5/5 Human Adiponectin ELISA kit, AdipoGen ).(Pharmaceuticals, Belmont Seoul, Korea (Camellia sinensis). 86 F.P.28. 2- Coefficient of variation - Inter-assay - Intra-assay 5- Intra-assay.[26] (WHO ) 0 kg/m 2 25 (BMI). 2 - ) (.. Stratified. 8. ). ) (0/ kg. (0/ cm... 0-2. -80 0C GPO-PAP GOD/PAP Endpoint. (HDL) Randox.(Hitachi 902) (OGTT). [27] - World Health Organization
... : 72 Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209. -0/) 0-0/0.( % 22/2 %/.(P=0/09). ] HbAC (P =0/02) 89/5±6/7 2/5±57/ [(P=0/0) 7/7±/5 5/9± 0/5 2/±2/9 8/± 8/6). (P=0/0). %7 HbAC %7) HbAc %75 ( HbAc > %/.(P= 0/05).. 80 50) 500. ( 500. 8. ± 5 SPSS Paired t-test. t-test... Chi-square 0 /05. 2 72 66 (%9.5) 6 ±. (%80.5) 0/9±0/06 kg/m 2 29/90±/9 5±.. 8 6 26.. (P=0/07) 2 (P= 0/00). HbAC 2 - Microcrystalline cellulose
7 ( ). - 5 ± ( ) 68±5 ( ) 29/9±/ (kg/m2) 70±62 (mg/dl) Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209 27±8 (mg/dl) 2 7 /6±/8 (%)Hb AC /7±6 (µlu/ml) 6/9±/9 (µg/ml) 7/2±/8 (ng/ml) 7/±0/5 (ng/ml) ±0/ (ng/ml) HbAc; glycosylated hemoglobin AC. ± * -2 26= 29/8±/6 0±/ 5 (kg/m2) 0/90±0/07 0/9±0/ 06 69±70 62± 65 (mg/dl) 220±77 27± 85 (mg/dl) 2 7/2±/8 7 /2±/ 6 (%)HbAC 6/7±8/9 5/9±7/ *(µlu/ml) 8/±2/6 6/8±/ (µg/ml) 7/8±/ 7/±8/ 5 (ng/ml) ±0/5 /±0/ (ng/ml) 5/±9/ 2/6± 0 (ng/ml) -0/±0/7 0/0±0/ /±0/2 0/8±0/ 5 * HbAc; glycosylated hemoglobin Ac.(P< 0/05) P *. ±
... : 7 Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209-6= 29/8± 29/7± (kg/m2) 0/9±0/07 0/8±0/ 05 85±72 75± 62 (mg/dl) 206±6 2± 8 (mg/dl) 2 8/±2 7 /6± 2 (%)Hb AC 5/5±7 /±/ (µlu/ml) 7/±5/ 7/±/ (µg/ml) 6/±/9 8/6±5/ 6 (ng/ml) 0/9±0/ 0/9±0/ (ng/ml) 5/±0/2 5±0/ (ng/ml) -0/±0/ -0/±0/ 6 /±0/ /±0/ HbAc; glycosylated hemoglobin AC.(P> 0/05) P *. ± [2] Fukino 2 HbAC Ryu. []. HbAC.[0]... mrna.[] 2.[28] 2..[29] 2...[0 ] HbAC.
75 ( ). Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209.[7 9] [0] Okazaki Rosato. []. HbAC....[2]. [] Shen In vivo 6 In. mrna vitro.[5].[6]. [7] Kanazawa. HbAC BMI BMI Kanazawa. 0.. 2.[8 6 22].. HbAC - Deoxypyridinoline - Fenton reaction 2- Caspase
... : 76 Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209. Räkel, A., Sheehy, O., Rahme, E., LeLorier, J.Osteoporosis among patients with type and type 2 diabetes, Diabetes Metab 2008; :9 205. 2. Forsen, L., Meyer, H.E., Midthjell, K., Edna, T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 999; 2:920 925.. Herskind, A.M., Christensen, K., Norgaard- Andersen, K., Andersen, J.F. Diabetes mellitus and healing of closed fractures. Diabetes Metab 992; 8:6 6.. Hofbauer, L., Brueck, C.C., Singh, S.K., Dobnig, H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007; 22:7 28. 5. Inzerillo, A., Epstein, S. Osteoporosis and diabetes mellitus. Rev Endocrine Metab Disord 200; 5:26 268. 6. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 998; 9:29 7. 7. Hakeda, Y., Kobayashi, Y., Yamaguchi, K., Yasuda, H., Tsuda, E., Higashio, K., Miyata, T., Kumegawa, M. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts, Biochem. Biophys. Res. Commun 998; 25: 796 80. 8. Suzuki, K., Kurose, T., Takizawa, M., Maruyama, M., Ushikawa, K., Kikuyama, M. Sugimoto, C., Seino, Y., Nagamatsu, S., Ishida, H. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclatogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral, Diabetes Res. Clin. Pract 2005; 68:7 25. 9. Epstein, S. Bone-derived proteins. Trends Endocr Metab 989; :9-0. Ishida, H., Seino, Y., Takeshita, N., Kurose, T., Tsuji, K., Okamoto, Y. Someya, Y., Hara, K., Akiyama, Y., Imura, H. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes. Acta Endocrinol (Copenh.) 992; 27: 8 85.. Suzuki, K., Ishida, H., Takeshita, N., Taguchi, Y., Sugimoto, C., Nosaka, K.Circulating levels of tartrate-resident acid phosphatase in rat models of non-insulin-dependent diabetes mellitus. J. Diabetes Complications 998; 2: 76 80. 2. Suzuki, K., Kurose, T., Takizawa, M., Maruyama, M., Ushikawa, K., Kikuyama, M., Sugimoto, C., Seino, Y., Nagamatsu, S., Ishida, H., Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the Ĥ preventive role of osteoclatogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral, Diabetes Res. Clin. Pract 2005; 68: 7 25.. Chesnut, C.H. rd., Bell, N.H., Clark, G.S., Drinkwater, B.L., English, S.C., Johnson, C.C. Jr., Notelovitz, M., Rosen, C., Cain, D.F., Flessland, K.A., Mallinak, N.J.Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 997; 02:29 7.. Raisz, L., Smith, J.A., Trahiotis, M., Fall, P., Shoukri, K., Digennaro, J. Sacco-Gibson, N. Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. Osteoporos Int 2000; :65 620. 5. Delaisse, J.M., Eeckhout, Y., Vaes, G. Inhibition of bone resorption in culture by (+)-catechin. Biochemical Pharmacology 986; 5:09 09. 6. Nakagawa, H., Wachi, M., Woo, J.T., Kato, M., Kasai, S., Takahashi, F., Lee, I.S., Nagai, K. Fenton reaction is primarily involved in a mechanism of ()-epigallocatechin--gallate to induce osteoclastic cell death. Biochemical & Biophysical Research Communications 2002; 292:9 0. 7. Yun, J.H., Kim, C.S., Cho, K.S., Chai J.K, Kim C.K, Choi S.H. (-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 26.7 cells. Journal of Periodontal Research 2007; 2:22-28. 8. Morinobu, A., Biao, W., Tanaka, S., Horiuchi, M., Jun, L., Tsuji, G., Sakai, Y., Kurosaka, M., Kumagai, S. (-)-Epigallocatechin--gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis and Rheumatism 2008; 58:202 208. 9. 9- Vali, B., Rao, L.G., El-Sohemy, A. Epigallocatechin--gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007; 8: 7 20. Nakagawa, H., Wachi, M., Woo, J.T, Kato, M., Kasai, S., Takahashi, F., Lee, I.S., Nagai, K. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin--gallate to induce osteoclastic cell death. Biochem Biophys Res Commun. 2002; 292:9 0. 2. Islam, S., Islam, N., Kermode, T. Johnstone, B., Mukhtar, H., Moskowitz, R.W., Goldberg, V.M., Malemud, C.J., Haqqi, T.M. Involvement of caspase- in epigallocatechin--gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 2000; 270:79 797. 22. Yun, J.H., Pang, E.K., Kim, C.S., Choi, S.H. Inhibitory effects of green tea polyphenol (-)-
77 ( ). Downloaded from ijdld.tums.ac.ir at 5:5 IRDT on Friday March 22nd 209 epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 200; 9:00 07. 2. Muraki, S., Yamamoto, S., Ishibashi, H., Oka, H., Yoshimura, N., Kawaguchi, H., Nakamura, K. Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci 2007; 2:7-20. 2. Shen, C.L., Wang, P., Guerrieri, J., Yeh, J.K., Wang, J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008; 9: 979-90. 25. Chen, C.H., Ho, M.L., Chang, J.K., Hung, S.H., Wang, G.J. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int 2005; 6: 209-205. 26. Alberti, K.G., Zimmet, P.Z, Definition, diagnosis and classification of diabetes mellitus and its disorders.. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 998; 5: 59 55. 27. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C.. Homeostasis model assessment: insulin resistance and _cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 985; 28: 2 9. 28. Narayan, K.M., Boyle, J.P, Thompson, T.J., Sorensen, S.W., Williamson, D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 200; 290: 88-890. 29. Hofbauer, L, Brueck, C.C., Singh, S.K., Dobnig, H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res, 2007; 22: 7 28. 0. Fukino, Y., Ikeda, A., Maruyama, K., Aoki, N., Okubo, T., Iso, H.Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2008; 62: 95 960.. Ryu, O.H., Lee, J., Lee, K.W., Kim, H.Y., J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi and K.M. Choi, Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2-diabetes patients. Diabetes Res Clin Pract 2006; 7: 56 58. 2. Fukino, Y, Shimbo, M, Aoki, N, Okubo, T, Iso, H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 2005; 5: 5 2.. Nuche-Berenguer, B., Moreno, P., Esbrit, P., Dapía, S., Caeiro, J.R., Cancelas, J., Haro-Mora, J.J., Villanueva-Peñacarrillo, M.L. Effect of GLP- Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States. Calcif Tissue Int 2009; 5.. Shen, C.L., Wang, P., Guerrieri, J., Yeh, J.K., Wang, J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008; 9: 979-990. 5. Botolin, S., McCabe, L, R. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006; 99: -2. 6. Manios, Y., Moschonis, G., Panagiotakos, D.B., Farajian, P., Trovas, G., Lyritis, G.P. Changes in biochemical indices of bone metabolism in postmenopausal women following a dietary intervention with fortified dairy products. J Hum Nutr Diet 2009; 22: 56-65. 7. Kanazawa, I., Yamaguchi, T., Yamamoto, M., Yamauchi, M., Kurioka, S., Yano, S., Sugimoto, T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 9: 5-9. 8. Islam, S, Islam, N, Kermode, T, Johnstone, B, Mukhtar, H, Moskowitz, R.W, Goldberg, V.M, Malemud, C.J, Haqqi, T.M. Involvement of caspase- in epigallocatechin--gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 2000; 270: 79-797. 9. Sayinalp, S, Gedik, O, Koray, Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int 995; 57: 22 25. 0. Okazaki, R., Totsuka, Y., Hamano, K., Ajima, M., Miura, M., Hirota, Y., Hata, K., Fukumoto, S., Matsumoto, T. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 997; 82: 295 2920.. Rosato, M.T., Schneider, S.H., Shapses, S.A. Bone turnover and insulin-like growth factor- levels increase after improved glycemic control in non insulin-dependent diabetes mellitus. Calcif Tissue Int 998; 6: 07. 2. Palacios, S, Castelo-Branco, C, Cifuentes, I, von Helde, S, Baro, L, Tapia-Ruano, C, Menendez, C, Rueda, C. Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial. Menopause 2005; 2: 6 68.